TY  - GEN
AU  - Naume,Bjørn
AU  - Synnestvedt,Marit
AU  - Falk,Ragnhild Sørum
AU  - Wiedswang,Gro
AU  - Weyde,Kjetil
AU  - Risberg,Terje
AU  - Kersten,Christian
AU  - Mjaaland,Ingvil
AU  - Vindi,Lise
AU  - Sommer,Hilde H
AU  - Sætersdal,Anna Barbro
AU  - Rypdal,Maria Christine
AU  - Bendigtsen Schirmer,Cecilie
AU  - Wist,Erik Andreas
AU  - Borgen,Elin
TI  - Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer
SN  - 1527-7755
PY  - 2015///0212
KW  - Antineoplastic Agents, Phytogenic
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Bone Marrow Cells
KW  - chemistry
KW  - Breast Neoplasms
KW  - Chemotherapy, Adjuvant
KW  - Chi-Square Distribution
KW  - Cyclophosphamide
KW  - Disease-Free Survival
KW  - Docetaxel
KW  - Drug Administration Schedule
KW  - Epirubicin
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Immunohistochemistry
KW  - Infusions, Intravenous
KW  - Kaplan-Meier Estimate
KW  - Keratins
KW  - analysis
KW  - Ki-67 Antigen
KW  - Middle Aged
KW  - Neoplastic Cells, Circulating
KW  - Norway
KW  - Predictive Value of Tests
KW  - Proportional Hazards Models
KW  - Prospective Studies
KW  - Retreatment
KW  - Risk Factors
KW  - Taxoids
KW  - Time Factors
KW  - Treatment Failure
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Webcast
UR  - https://doi.org/10.1200/JCO.2014.56.9327
ER  -